These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6968788)

  • 1. HLA variants of human lymphoblastoid cell lines as targets for cytotoxic T cells: analysis of CTL reactivity against 2 HLA-DR variants.
    Newman W; Pious D; Gladstone P
    J Immunol; 1980 Dec; 125(6):2515-20. PubMed ID: 6968788
    [No Abstract]   [Full Text] [Related]  

  • 2. Specificity of mouse cytotoxic T lymphocytes stimulated with either HLA-A and -B or HLA-DR antigens reconstituted into phospholipid vesicles.
    Engelhard VH; Kaufman JF; Strominger JL; Burakoff SJ
    J Exp Med; 1980 Aug; 152(2 Pt 2):54s-64s. PubMed ID: 6157770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Education of mouse lymphocytes against human lymphoblastoid cell lines: specific recognition of determinants independent of serologically defined HLA allotypes and Epstein-Barr virus-coded antigens.
    Carnaud C; Errasti P; van der Gaag R
    Eur J Immunol; 1979 Oct; 9(10):802-8. PubMed ID: 93053
    [No Abstract]   [Full Text] [Related]  

  • 4. Human cytotoxic response in vitro to trinitrophenyl-modified autologous cells. II. Diversity of self determinants recognized in association with TNP.
    Shaw S; Shearer GM
    J Immunol; 1978 Jul; 121(1):290-9. PubMed ID: 78944
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of human CML target. HLA-B locus (B12) antigen variants defined by CTL generated between B locus-identical (B12) responder-stimulator pairs.
    Kato S; Iványi P; Lacko E; Breur B; Du Bois R; Eijsvoogel VP
    J Immunol; 1982 Feb; 128(2):949-55. PubMed ID: 6976390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8+ T cells.
    Kausche S; Wehler T; Schnürer E; Lennerz V; Brenner W; Melchior S; Gröne M; Nonn M; Strand S; Meyer R; Ranieri E; Huber C; Falk CS; Herr W
    Cancer Res; 2006 Dec; 66(23):11447-54. PubMed ID: 17145892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crossreactive cytotoxic T-cell line expanded by T-cell growth factor.
    Dubey DP; Stux S; Tsong YK; Yunis E
    Transplant Proc; 1981 Mar; 13(1 Pt 2):1153-6. PubMed ID: 6791334
    [No Abstract]   [Full Text] [Related]  

  • 8. Specificity of human cytotoxic responses to chemically modified autologous cells.
    Shaw S; Levis WR; Dattner AM; Shearer GM
    Transplant Proc; 1978 Dec; 10(4):937-41. PubMed ID: 83727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza virus-specific cytotoxic T cells are restricted by multiple HLA-A3-related self antigens: evidence for recognition of distinct self structures in conjunction with different foreign antigens.
    Biddison WE; Shearer GM; Shaw S
    J Immunol; 1981 Dec; 127(6):2231-5. PubMed ID: 6975312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-unrestricted killing of HSV-1-infected mononuclear cells. Involvement of either gamma/delta+ or alpha/beta+ human cytotoxic T lymphocytes.
    Maccario R; Revello MG; Comoli P; Montagna D; Locatelli F; Gerna G
    J Immunol; 1993 Feb; 150(4):1437-45. PubMed ID: 8381835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivity of HLA typing sera against cultured lymphoblastoid cell lines and purified peripheral B and T cells from the same original donors.
    Nakayama E; Itakura K
    Jpn J Exp Med; 1977 Oct; 47(5):425-7. PubMed ID: 304500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificities in natural cell-mediated cytotoxicity against lymphoblastoid cell lines. I. Selective inhibition by cross-competition.
    Koide Y; Takasugi M
    Eur J Immunol; 1978 Nov; 8(11):818-22. PubMed ID: 82513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective in vitro expansion of HLA class I-restricted HIV-1 Gag-specific CD8+ T cells: cytotoxic T-lymphocyte epitopes and precursor frequencies.
    van Baalen CA; Klein MR; Geretti AM; Keet RI; Miedema F; van Els CA; Osterhaus AD
    AIDS; 1993 Jun; 7(6):781-6. PubMed ID: 7689847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human cytotoxic T-cell lines with restricted specificity for squamous cell carcinoma of the head and neck.
    Yasumura S; Hirabayashi H; Schwartz DR; Toso JF; Johnson JT; Herberman RB; Whiteside TL
    Cancer Res; 1993 Mar; 53(6):1461-8. PubMed ID: 8443824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-killing phenomenon during induction of cytotoxic activity against autologous leukemic cells or autologous Epstein-Barr virus-transformed lymphoblastoid B-cell line.
    Maeda Y; Hijikata Y; Yamaguchi T; Morita Y; Kanamaru A
    Leuk Res; 2008 Mar; 32(3):510-1. PubMed ID: 17628665
    [No Abstract]   [Full Text] [Related]  

  • 16. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
    Tremblay N; Fontaine P; Perreault C
    Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human cytotoxic T cell response to influenza A vaccination.
    McMichael AJ; Gotch F; Cullen P; Askonas B; Webster RG
    Clin Exp Immunol; 1981 Feb; 43(2):276-84. PubMed ID: 6974066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognition of HLA and minor alloantigens on human target cells by allostimulated cytotoxic effectors in vitro.
    Pierson G; Elkins W
    Transplant Proc; 1981 Dec; 13(4):1901-5. PubMed ID: 6977223
    [No Abstract]   [Full Text] [Related]  

  • 19. HLA-promiscuous Th1-cell reactivity of MPT64 (Rv1980c), a major secreted antigen of Mycobacterium tuberculosis, in healthy subjects.
    Mustafa AS
    Med Princ Pract; 2009; 18(5):385-92. PubMed ID: 19648762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-reactive T cell clones from unrelated individuals reveal similarities in peptide presentation between HLA-B27 and HLA-DR2.
    López D; Barber DF; Villadangos JA; López de Castro JA
    J Immunol; 1993 Apr; 150(7):2675-86. PubMed ID: 7681078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.